Search results
Valneva's (VALN) CHIKV Vaccine Gets Health Canada's Approval
Zacks via Yahoo Finance· 9 hours agoValneva SE VALN, a specialty vaccine company, has achieved a significant milestone with the approval...
‘A head-in-the-sand approach’: The U.S. strategic drug stockpile is inadequate for a bird flu...
Fortune via Yahoo Finance· 7 hours agoBaloxavir, which requires a single dose and works differently than other flu antivirals, has been...
Pressure on cholera vaccine stocks 'decreasing': Gavi alliance
AFP via Yahoo News· 7 days agoA resurgence of cholera across Africa has driven an urgent need for more vaccine doses, but stock...
FDA Approves Pneumococcal Vax Designed Specifically for Adults
MedPage Today· 7 days agoSpecifically designed for an adult population, the single-dose vaccine is indicated for active...
More African nations focus on HPV vaccination against cervical cancer, but hesitancy remains
Associated Press via Yahoo News· 20 hours agoYunusa Bawa spends a lot of time talking about the vaccine for the human papillomavirus that is...
A study conducted by IDIAPJGol and ISGlobal recommends enhancing immunity against COVID-19 in cancer...
Hardwood Paroxysm· 4 days agoWork that has just been published in the journal Nature CommunicationsIt recommends administering...
New study involving nearly 185,000 patients recommends strengthening immunity against COVID-19 in...
Medical Xpress· 6 days agoThe research, published in the journal Nature Communications, recommends administering additional doses of the vaccine among this risk population. Cancer patients are at increased ...
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
BioPharma Dive via Yahoo Finance· 7 days agoThe advisory committee is set to meet on June 27. Merck set the price of Capvaxive at $287 per the ...
FDA approves 1st adult vaccine for bacterial pneumonia
Becker’s Hospital Review· 7 days ago"Merck receives FDA approval for Capvaxive, a new vaccine to protect adults from pneumococcus, a bacteria that can cause serious diseases like pneumonia."
Moderna shares rise as Argus lifts price target to $150 By Investing.com
Investing.com· 4 days agoThe firm's decision follows the U.S. Food and Drug Administration's (FDA) approval of Moderna's...